|
G |
Ache |
acetylcholinesterase |
decreases activity multiple interactions decreases expression |
ISO EXP |
Pyridostigmine Bromide results in decreased activity of ACHE protein [Pyridostigmine Bromide co-treated with DEET] results in decreased activity of ACHE protein; [Pyridostigmine Bromide co-treated with DEET] results in increased activity of ACHE protein; [Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in decreased activity of ACHE protein; [Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of ACHE protein; [Pyridostigmine Bromide co-treated with Permethrin] results in decreased activity of ACHE protein; [Pyridostigmine Bromide co-treated with Permethrin] results in increased activity of ACHE protein; asoxime chloride affects the reaction [Pyridostigmine Bromide results in decreased activity of ACHE protein]; asoxime chloride promotes the reaction [Pyridostigmine Bromide inhibits the reaction [Soman results in decreased activity of ACHE protein]]; Pyridostigmine Bromide inhibits the reaction [Soman results in decreased activity of ACHE protein] Pyridostigmine Bromide inhibits the reaction [Soman results in decreased activity of ACHE protein]; SOD2 protein SNP promotes the reaction [Pyridostigmine Bromide results in decreased expression of ACHE protein] |
CTD |
PMID:11248143 PMID:14751452 PMID:21354413 PMID:21414391 PMID:30176331 PMID:30682440 PMID:31175926 More...
|
|
NCBI chr12:19,406,133...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Ager |
advanced glycosylation end product-specific receptor |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of AGER protein |
CTD |
PMID:32832901 |
|
NCBI chr20:4,148,150...4,151,361
Ensembl chr20:4,147,890...4,151,078
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of AIF1 protein |
CTD |
PMID:27984134 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Alb |
albumin |
affects binding |
ISO |
Pyridostigmine Bromide binds to ALB protein |
CTD |
PMID:12029383 |
|
NCBI chr14:17,607,397...17,622,814
Ensembl chr14:17,607,381...17,622,836
|
|
G |
Als2 |
alsin Rho guanine nucleotide exchange factor ALS2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ALS2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 9:60,613,182...60,686,394
Ensembl chr 9:60,613,167...60,670,737
|
|
G |
Apc |
APC regulator of WNT signaling pathway |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of APC mRNA |
CTD |
PMID:28659758 |
|
NCBI chr18:25,828,558...25,925,511
Ensembl chr18:25,864,222...25,922,696
|
|
G |
Apoe |
apolipoprotein E |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of APOE mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Atp5f1a |
ATP synthase F1 subunit alpha |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1A mRNA |
CTD |
PMID:28659758 |
|
NCBI chr18:71,292,406...71,300,342
Ensembl chr18:71,292,374...71,300,794
|
|
G |
Atp5f1b |
ATP synthase F1 subunit beta |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP5F1B mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 7:515,454...521,858
Ensembl chr 7:515,460...567,273
|
|
G |
Atp6ap1 |
ATPase H+ transporting accessory protein 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP6AP1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr X:152,079,954...152,087,034
Ensembl chr X:152,079,865...152,087,034
|
|
G |
Atp6v0a2 |
ATPase H+ transporting V0 subunit a2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ATP6V0A2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr12:31,947,220...31,979,875
Ensembl chr12:31,822,733...32,007,069
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions decreases expression |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of BAX protein SOD2 protein SNP affects the reaction [Pyridostigmine Bromide results in decreased expression of BAX mRNA]; SOD2 protein SNP promotes the reaction [Pyridostigmine Bromide results in decreased expression of BAX protein] Pyridostigmine Bromide results in decreased expression of BAX mRNA; Pyridostigmine Bromide results in decreased expression of BAX protein |
CTD |
PMID:12587291 PMID:31175926 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
multiple interactions decreases activity |
EXP |
[Pyridostigmine Bromide co-treated with DEET] results in increased activity of BCHE protein; [Pyridostigmine Bromide co-treated with Permethrin] results in increased activity of BCHE protein Pyridostigmine Bromide results in decreased activity of BCHE protein |
CTD |
PMID:14751452 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
ISO |
SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of BCL2 mRNA] Pyridostigmine Bromide results in decreased expression of BCL2 mRNA; Pyridostigmine Bromide results in decreased expression of BCL2 protein |
CTD |
PMID:31175926 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bcl6 |
BCL6, transcription repressor |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of BCL6 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr11:76,854,090...76,877,389
Ensembl chr11:76,854,090...76,877,389
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of BDNF protein; NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of BDNF protein] |
CTD |
PMID:32832901 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
decreases expression multiple interactions |
ISO |
Pyridostigmine Bromide results in decreased expression of CASP3 mRNA; Pyridostigmine Bromide results in decreased expression of CASP3 protein SOD2 protein SNP affects the reaction [Pyridostigmine Bromide results in decreased expression of CASP3 mRNA]; SOD2 protein SNP affects the reaction [Pyridostigmine Bromide results in decreased expression of CASP3 protein] |
CTD |
PMID:31175926 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
multiple interactions affects expression decreases expression |
ISO |
SOD2 protein SNP affects the reaction [Pyridostigmine Bromide affects the expression of CASP8 mRNA] Pyridostigmine Bromide results in decreased expression of CASP8 protein |
CTD |
PMID:31175926 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Cat |
catalase |
multiple interactions decreases expression increases activity |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CAT mRNA SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of CAT mRNA] Pyridostigmine Bromide results in increased activity of CAT protein |
CTD |
PMID:28659758 PMID:31175926 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CCL2 mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccl3 |
C-C motif chemokine ligand 3 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of CCL3 protein |
CTD |
PMID:28659758 |
|
NCBI chr10:68,451,388...68,452,938
Ensembl chr10:68,451,388...68,452,938
|
|
G |
Ccs |
copper chaperone for superoxide dismutase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CCS mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:202,113,792...202,134,931
Ensembl chr 1:202,113,804...202,134,915
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CD68 mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Chat |
choline O-acetyltransferase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] results in increased activity of CHAT protein |
CTD |
PMID:11248143 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with Permethrin co-treated with DEET] promotes the reaction [AFDX 384 binds to CHRM2 protein]; [Pyridostigmine Bromide co-treated with Permethrin] promotes the reaction [AFDX 384 binds to CHRM2 protein]; Pyridostigmine Bromide promotes the reaction [AFDX 384 binds to CHRM2 protein] |
CTD |
PMID:11248143 PMID:14751452 |
|
NCBI chr 4:65,015,408...65,149,104
Ensembl chr 4:65,014,144...65,149,103
|
|
G |
Cldn2 |
claudin 2 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of CLDN2 protein |
CTD |
PMID:29751049 |
|
NCBI chr X:103,459,870...103,473,794
Ensembl chr X:103,459,780...103,474,838
|
|
G |
Cldn5 |
claudin 5 |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 mRNA; [Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of CLDN5 protein |
CTD |
PMID:32832901 |
|
NCBI chr11:82,212,822...82,214,248
Ensembl chr11:82,211,475...82,214,992
|
|
G |
Cort |
cortistatin |
multiple interactions |
ISO |
[CORT protein co-treated with Pyridostigmine Bromide co-treated with DEET co-treated with Isoflurophate] affects the secretion of IL10 protein; [CORT protein co-treated with Pyridostigmine Bromide co-treated with DEET] affects the secretion of IL10 protein; [Pyridostigmine Bromide co-treated with DEET] affects the reaction [[CORT protein co-treated with Isoflurophate] affects the secretion of IL5 protein]; [Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [[CORT protein co-treated with Isoflurophate] results in increased expression of LIF mRNA]; [Pyridostigmine Bromide co-treated with DEET] promotes the reaction [CORT protein inhibits the reaction [Isoflurophate results in increased expression of IL1B mRNA]]; [Pyridostigmine Bromide co-treated with DEET] promotes the reaction [CORT protein inhibits the reaction [Isoflurophate results in increased expression of IL6 mRNA]]; [Pyridostigmine Bromide co-treated with DEET] promotes the reaction [CORT protein inhibits the reaction [Isoflurophate results in increased expression of OSM mRNA]] |
CTD |
PMID:30339781 |
|
NCBI chr 5:159,560,591...159,562,032
|
|
G |
Cox5b |
cytochrome c oxidase subunit 5B |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of COX5B mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 9:38,921,980...38,923,806
Ensembl chr 9:38,921,967...38,925,052
|
|
G |
Cox6a1 |
cytochrome c oxidase subunit 6A1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of COX6A1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr12:41,261,983...41,265,037
Ensembl chr12:41,261,967...41,265,041
|
|
G |
Cox7a2l |
cytochrome c oxidase subunit 7A2 like |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of COX7A2L mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 6:11,184,064...11,198,287
Ensembl chr 6:11,184,285...11,198,273
|
|
G |
Csf2 |
colony stimulating factor 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CSF2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:38,386,945...38,388,926
Ensembl chr10:38,386,945...38,389,199
|
|
G |
Ctsb |
cathepsin B |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CTSB mRNA |
CTD |
PMID:28659758 |
|
NCBI chr15:37,389,636...37,410,508
Ensembl chr15:37,389,629...37,410,500
|
|
G |
Cxcl10 |
C-X-C motif chemokine ligand 10 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of CXCL10 protein |
CTD |
PMID:28659758 |
|
NCBI chr14:15,704,772...15,706,969
Ensembl chr14:15,704,758...15,706,975
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [Isoflurophate results in increased secretion of CXCL1 protein] |
CTD |
PMID:30339781 |
|
NCBI chr14:17,287,727...17,289,451
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyc1 |
cytochrome c-1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CYC1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 7:108,067,106...108,069,483
Ensembl chr 7:108,067,115...108,069,479
|
|
G |
Cygb |
cytoglobin |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of CYGB mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:101,877,675...101,887,442
Ensembl chr10:101,877,676...101,887,442
|
|
G |
Dhcr24 |
24-dehydrocholesterol reductase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of DHCR24 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 5:121,344,552...121,371,124
Ensembl chr 5:121,344,575...121,371,137
|
|
G |
Dnm2 |
dynamin 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of DNM2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 8:19,978,313...20,060,162
Ensembl chr 8:19,978,400...20,060,157
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions decreases expression |
ISO |
SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of DNMT1 mRNA] |
CTD |
PMID:31175926 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Duox2 |
dual oxidase 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of DUOX2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 3:109,223,809...109,247,023
Ensembl chr 3:109,226,924...109,245,902
|
|
G |
Ercc6 |
ERCC excision repair 6, chromatin remodeling factor |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ERCC6 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr16:7,764,983...7,835,587
Ensembl chr16:7,765,013...7,835,587
|
|
G |
Fgf2 |
fibroblast growth factor 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of FGF2 protein |
CTD |
PMID:28659758 |
|
NCBI chr 2:120,236,328...120,290,673
Ensembl chr 2:120,236,328...120,291,221
|
|
G |
Fmo2 |
flavin containing dimethylaniline monoxygenase 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of FMO2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr13:75,221,149...75,244,377
Ensembl chr13:75,224,402...75,244,308
|
|
G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GCLC mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of GFAP protein |
CTD |
PMID:27984134 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Glyr1 |
glyoxylate reductase 1 homolog |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GLYR1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:10,532,036...10,567,639
Ensembl chr10:10,532,154...10,567,637
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
decreases expression multiple interactions |
ISO |
Pyridostigmine Bromide results in decreased expression of GPX1 mRNA SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of GPX1 mRNA] |
CTD |
PMID:31175926 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GPX3 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gpx4 |
glutathione peroxidase 4 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GPX4 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 7:9,650,186...9,652,982
Ensembl chr 7:9,650,185...9,652,982
|
|
G |
Gpx6 |
glutathione peroxidase 6 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GPX6 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr17:43,408,472...43,416,091
Ensembl chr17:43,408,472...43,416,091
|
|
G |
Gpx7 |
glutathione peroxidase 7 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GPX7 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 5:123,145,151...123,153,141
Ensembl chr 5:123,144,331...123,153,004
|
|
G |
Gsr |
glutathione-disulfide reductase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GSR mRNA |
CTD |
PMID:28659758 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Gstk1 |
glutathione S-transferase kappa 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GSTK1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 4:71,118,979...71,123,298
Ensembl chr 4:71,118,896...71,123,292
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of GSTP1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hmgb1 |
high mobility group box 1 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein; [Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of HMGB1 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of HMGB1 protein] |
CTD |
PMID:29751049 PMID:32832901 |
|
NCBI chr12:5,972,950...5,979,658
Ensembl chr12:5,901,586...5,978,565 Ensembl chr16:5,901,586...5,978,565
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of HMOX1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ice2 |
interactor of little elongation complex ELL subunit 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of ICE2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 8:70,043,419...70,085,217
Ensembl chr 8:70,043,424...70,084,995
|
|
G |
Idh1 |
isocitrate dehydrogenase (NADP(+)) 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of IDH1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 9:66,534,146...66,563,703
Ensembl chr 9:66,534,146...66,563,708
|
|
G |
Ift172 |
intraflagellar transport 172 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of IFT172 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 6:25,081,933...25,121,271
Ensembl chr 6:25,081,980...25,120,860
|
|
G |
Il10 |
interleukin 10 |
multiple interactions |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in decreased expression of IL10 mRNA [CORT protein co-treated with Pyridostigmine Bromide co-treated with DEET co-treated with Isoflurophate] affects the secretion of IL10 protein; [CORT protein co-treated with Pyridostigmine Bromide co-treated with DEET] affects the secretion of IL10 protein; [Pyridostigmine Bromide co-treated with DEET co-treated with Isoflurophate] affects the secretion of IL10 protein; [Pyridostigmine Bromide co-treated with DEET] affects the secretion of IL10 protein; [Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [Isoflurophate results in increased expression of IL10 mRNA] |
CTD |
PMID:28659758 PMID:30339781 |
|
NCBI chr13:42,472,625...42,477,308
Ensembl chr13:42,472,839...42,477,313
|
|
G |
Il15 |
interleukin 15 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of IL15 protein |
CTD |
PMID:28659758 |
|
NCBI chr19:25,640,025...25,706,818
Ensembl chr19:25,640,251...25,706,820
|
|
G |
Il18 |
interleukin 18 |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL18 protein; NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL18 protein] |
CTD |
PMID:32832901 |
|
NCBI chr 8:50,904,630...50,932,887
Ensembl chr 8:50,906,960...50,932,887
|
|
G |
Il1a |
interleukin 1 alpha |
multiple interactions |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of IL1A protein; [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of IL1A mRNA [Pyridostigmine Bromide co-treated with DEET] results in increased secretion of IL1A protein |
CTD |
PMID:28659758 PMID:30339781 |
|
NCBI chr 3:116,526,601...116,537,055
Ensembl chr 3:116,526,604...116,536,822
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of IL1B protein [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA; [Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [Isoflurophate results in increased expression of IL1B mRNA]; [Pyridostigmine Bromide co-treated with DEET] promotes the reaction [CORT protein inhibits the reaction [Isoflurophate results in increased expression of IL1B mRNA]]; [Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL1B protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of and results in increased secretion of IL1B protein]; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of IL1B mRNA]; NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL1B protein] |
CTD |
PMID:28659758 PMID:29751049 PMID:30339781 PMID:32832901 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with DEET] results in increased secretion of IL2 protein |
CTD |
PMID:30339781 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in decreased expression of IL4 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il5 |
interleukin 5 |
multiple interactions |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of IL5 protein [Pyridostigmine Bromide co-treated with DEET] affects the reaction [[CORT protein co-treated with Isoflurophate] affects the secretion of IL5 protein] |
CTD |
PMID:28659758 PMID:30339781 |
|
NCBI chr10:37,874,342...37,877,213
Ensembl chr10:37,874,342...37,877,213
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of IL6 protein; [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of IL6 mRNA [Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of IL6 mRNA; [Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [Isoflurophate results in increased expression of IL6 mRNA]; [Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [Isoflurophate results in increased secretion of IL6 protein]; [Pyridostigmine Bromide co-treated with DEET] promotes the reaction [CORT protein inhibits the reaction [Isoflurophate results in increased expression of IL6 mRNA]]; [Pyridostigmine Bromide co-treated with DEET] results in increased secretion of IL6 protein; [Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL6 protein; NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL6 protein] |
CTD |
PMID:28500787 PMID:28659758 PMID:30339781 PMID:32832901 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Lep |
leptin |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased secretion of LEP protein] |
CTD |
PMID:29751049 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lhpp |
phospholysine phosphohistidine inorganic pyrophosphate phosphatase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of LHPP mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:187,403,390...187,494,577
Ensembl chr 1:187,403,433...187,494,578
|
|
G |
Lif |
LIF, interleukin 6 family cytokine |
multiple interactions decreases expression |
ISO |
[Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [[CORT protein co-treated with Isoflurophate] results in increased expression of LIF mRNA]; [Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [Isoflurophate results in increased expression of LIF mRNA] Pyridostigmine Bromide results in decreased expression of LIF mRNA |
CTD |
PMID:28500787 PMID:30339781 |
|
NCBI chr14:79,131,049...79,140,486
Ensembl chr14:79,134,574...79,140,482
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of MAPK1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of MAPK3 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mapk8 |
mitogen-activated protein kinase 8 |
multiple interactions |
ISO |
[Chlorpyrifos co-treated with DEET co-treated with Pyridostigmine Bromide] results in increased phosphorylation of MAPK8 protein |
CTD |
PMID:34528356 |
|
NCBI chr16:8,638,897...8,721,960
Ensembl chr16:8,638,924...8,721,981
|
|
G |
Mpo |
myeloperoxidase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of MPO mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:72,594,883...72,608,862
Ensembl chr10:72,594,661...72,604,819
|
|
G |
Ndufa11 |
NADH:ubiquinone oxidoreductase subunit A11 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA11 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 9:1,550,487...1,554,546
Ensembl chr 9:1,550,468...1,555,601
|
|
G |
Ndufa8 |
NADH:ubiquinone oxidoreductase subunit A8 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA8 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 3:19,386,062...19,402,090
Ensembl chr 3:19,386,065...19,402,071
|
|
G |
Ndufa9 |
NADH:ubiquinone oxidoreductase subunit A9 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFA9 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 4:159,659,242...159,688,034
Ensembl chr 4:159,659,242...159,688,018
|
|
G |
Ndufb3 |
NADH:ubiquinone oxidoreductase subunit B3 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFB3 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 9:60,129,240...60,139,452
Ensembl chr 9:60,129,154...60,139,446
|
|
G |
Ndufb5 |
NADH:ubiquinone oxidoreductase subunit B5 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFB5 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 2:115,519,248...115,533,589
Ensembl chr 2:115,519,154...115,533,589
|
|
G |
Ndufs6 |
NADH:ubiquinone oxidoreductase subunit S6 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFS6 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:29,968,833...29,977,423
Ensembl chr 1:29,968,842...29,977,467
|
|
G |
Ndufs7 |
NADH:ubiquinone oxidoreductase core subunit S7 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFS7 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 7:9,452,556...9,460,135
Ensembl chr 7:9,450,392...9,460,195
|
|
G |
Ndufs8 |
NADH:ubiquinone oxidoreductase core subunit S8 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFS8 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:201,140,585...201,144,573
Ensembl chr 1:201,140,585...201,144,511
|
|
G |
Ndufv1 |
NADH:ubiquinone oxidoreductase core subunit V1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NDUFV1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:201,300,365...201,305,461
Ensembl chr 1:201,299,985...201,305,466
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and affects the localization of NFE2L2 protein |
CTD |
PMID:28659758 |
|
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NFKB1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Ngf |
nerve growth factor |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NGF mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 2:189,901,058...189,954,452
Ensembl chr 2:189,901,058...189,954,452
|
|
G |
Nlrp3 |
NLR family, pyrin domain containing 3 |
multiple interactions |
ISO |
NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of BDNF protein]; NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL18 protein]; NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL1B protein]; NLRP3 protein affects the reaction [[Pyridostigmine Bromide co-treated with Permethrin] results in increased expression of IL6 protein] |
CTD |
PMID:32832901 |
|
NCBI chr10:44,326,770...44,353,814
Ensembl chr10:44,328,566...44,352,811
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NQO1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nudt1 |
nudix hydrolase 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of NUDT1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
|
|
G |
Ocln |
occludin |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of OCLN protein] |
CTD |
PMID:29751049 |
|
NCBI chr 2:31,657,217...31,707,466
Ensembl chr 2:31,657,220...31,764,150
|
|
G |
Osm |
oncostatin M |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with DEET] inhibits the reaction [Isoflurophate results in increased expression of OSM mRNA]; [Pyridostigmine Bromide co-treated with DEET] promotes the reaction [CORT protein inhibits the reaction [Isoflurophate results in increased expression of OSM mRNA]] |
CTD |
PMID:30339781 |
|
NCBI chr14:79,103,638...79,108,500
Ensembl chr14:79,104,344...79,108,313
|
|
G |
Park7 |
Parkinsonism associated deglycase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PARK7 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 5:161,353,718...161,376,993
Ensembl chr 5:161,353,719...161,376,970
|
|
G |
Pfkp |
phosphofructokinase, platelet |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr17:63,729,743...63,794,026
Ensembl chr17:63,729,780...63,794,018
|
|
G |
Ppa1 |
inorganic pyrophosphatase 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PPA1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in decreased expression of PPARG mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prdx1 |
peroxiredoxin 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRDX1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 5:130,147,258...130,162,856
Ensembl chr 5:130,147,204...130,162,856
|
|
G |
Prdx2 |
peroxiredoxin 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRDX2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr19:23,180,927...23,186,217
Ensembl chr19:23,180,930...23,186,194
|
|
G |
Prdx5 |
peroxiredoxin 5 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRDX5 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:204,099,826...204,103,589
Ensembl chr 1:204,099,826...204,114,268
|
|
G |
Prdx6 |
peroxiredoxin 6 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRDX6 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr13:73,528,746...73,539,295
Ensembl chr13:73,528,210...73,539,355
|
|
G |
Prkaca |
protein kinase cAMP-activated catalytic subunit alpha |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRKACA mRNA |
CTD |
PMID:28659758 |
|
NCBI chr19:24,155,081...24,178,430
Ensembl chr19:24,155,090...24,178,430
|
|
G |
Prnp |
prion protein |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PRNP mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 3:119,186,073...119,201,513
Ensembl chr 3:119,177,485...119,203,937
|
|
G |
Psmb5 |
proteasome 20S subunit beta 5 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PSMB5 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr15:28,072,772...28,077,367
Ensembl chr15:28,072,781...28,077,440
|
|
G |
Ptgs1 |
prostaglandin-endoperoxide synthase 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of PTGS1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 3:19,584,015...19,605,589
Ensembl chr 3:19,584,015...19,605,586
|
|
G |
Scd |
stearoyl-CoA desaturase |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SCD1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scn11a |
sodium voltage-gated channel alpha subunit 11 |
increases expression multiple interactions |
EXP |
Pyridostigmine Bromide results in increased expression of SCN11A protein [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin co-treated with Chlorpyrifos] results in increased activity of SCN11A protein |
CTD |
PMID:24732443 PMID:29803855 |
|
NCBI chr 8:119,495,550...119,567,044
Ensembl chr 8:119,496,769...119,567,044
|
|
G |
Sdhb |
succinate dehydrogenase complex iron sulfur subunit B |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SDHB mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 5:153,264,906...153,285,570
Ensembl chr 5:153,264,899...153,314,293
|
|
G |
Selenop |
selenoprotein P |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SELENOP mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 2:52,498,123...52,508,409
Ensembl chr 2:52,498,339...52,508,852
|
|
G |
Slc25a10 |
solute carrier family 25 member 10 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC25A10 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:105,765,598...105,775,159
Ensembl chr10:105,765,372...105,773,556
|
|
G |
Slc25a20 |
solute carrier family 25 member 20 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC25A20 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 8:109,365,056...109,386,512
Ensembl chr 8:109,365,002...109,386,512
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc2a4 |
solute carrier family 2 member 4 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr10:54,666,015...54,671,581
Ensembl chr10:54,666,015...54,671,565
|
|
G |
Slc38a1 |
solute carrier family 38, member 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SLC38A1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 7:127,733,230...127,802,541
Ensembl chr 7:127,738,226...127,802,218
|
|
G |
Sod1 |
superoxide dismutase 1 |
affects expression multiple interactions |
ISO |
Pyridostigmine Bromide affects the expression of SOD1 mRNA SOD2 protein SNP affects the reaction [Pyridostigmine Bromide affects the expression of SOD1 mRNA] |
CTD |
PMID:31175926 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions decreases expression |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SOD2 mRNA SOD2 protein SNP affects the reaction [Pyridostigmine Bromide affects the expression of CASP8 mRNA]; SOD2 protein SNP affects the reaction [Pyridostigmine Bromide affects the expression of SOD1 mRNA]; SOD2 protein SNP affects the reaction [Pyridostigmine Bromide results in decreased expression of BAX mRNA]; SOD2 protein SNP affects the reaction [Pyridostigmine Bromide results in decreased expression of CASP3 mRNA]; SOD2 protein SNP affects the reaction [Pyridostigmine Bromide results in decreased expression of CASP3 protein]; SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of BCL2 mRNA]; SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of CAT mRNA]; SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of DNMT1 mRNA]; SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of GPX1 mRNA]; SOD2 protein SNP inhibits the reaction [Pyridostigmine Bromide results in decreased expression of SOD2 mRNA]; SOD2 protein SNP promotes the reaction [Pyridostigmine Bromide results in decreased expression of ACHE protein]; SOD2 protein SNP promotes the reaction [Pyridostigmine Bromide results in decreased expression of BAX protein] |
CTD |
PMID:28659758 PMID:31175926 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Sod3 |
superoxide dismutase 3 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SOD3 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr14:58,610,104...58,615,845
Ensembl chr14:58,609,958...58,615,990
|
|
G |
Sqstm1 |
sequestosome 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SQSTM1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr10:34,525,517...34,536,670
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA] |
CTD |
PMID:29751049 |
|
NCBI chr10:45,007,637...45,029,650
Ensembl chr10:45,007,637...45,029,650
|
|
G |
Srxn1 |
sulfiredoxin 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SRXN1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Surf1 |
SURF1, cytochrome c oxidase assembly factor |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of SURF1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 3:10,241,793...10,244,686
Ensembl chr 3:10,241,837...10,263,315
|
|
G |
Syp |
synaptophysin |
multiple interactions |
ISO |
[Pyridostigmine Bromide co-treated with Permethrin] results in decreased expression of SYP protein |
CTD |
PMID:25785457 |
|
NCBI chr X:14,849,444...14,864,553
Ensembl chr X:14,849,444...14,864,745
|
|
G |
Tlr4 |
toll-like receptor 4 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR4 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PFKP mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of PPARA mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SLC2A4 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of SREBF1 mRNA]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein] |
CTD |
PMID:29751049 |
|
NCBI chr 5:80,145,867...80,159,501
Ensembl chr 5:80,145,826...80,159,628
|
|
G |
Tlr5 |
toll-like receptor 5 |
multiple interactions |
ISO |
[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein]; TLR4 gene mutant form inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TLR5 protein] |
CTD |
PMID:29751049 |
|
NCBI chr13:94,634,778...94,658,992
Ensembl chr13:94,634,801...94,657,738
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions increases expression |
EXP ISO |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of TNF protein [Corticosterone co-treated with Pyridostigmine Bromide] results in increased expression of TNF mRNA; [Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA; Butyric Acid inhibits the reaction [[Permethrin co-treated with Pyridostigmine Bromide co-treated with Corticosterone] results in increased expression of TNF mRNA] Pyridostigmine Bromide results in increased expression of TNF mRNA |
CTD |
PMID:28500787 PMID:28659758 PMID:29751049 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of TP53 protein |
CTD |
PMID:12587291 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Txnrd1 |
thioredoxin reductase 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of TXNRD1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 7:20,830,042...20,914,990
Ensembl chr 7:20,830,045...20,907,863
|
|
G |
Txnrd2 |
thioredoxin reductase 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of TXNRD2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr11:82,519,996...82,568,156
Ensembl chr11:82,519,999...82,568,156
|
|
G |
Ucp1 |
uncoupling protein 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of UCP1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr19:24,808,782...24,816,853
Ensembl chr19:24,808,783...24,816,852
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of UCP2 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Uqcrb |
ubiquinol-cytochrome c reductase binding protein |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of UQCRB mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 7:63,814,784...63,820,150
Ensembl chr 7:63,814,797...63,820,150
|
|
G |
Uqcrc1 |
ubiquinol-cytochrome c reductase core protein 1 |
multiple interactions |
EXP |
[Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of UQCRC1 mRNA |
CTD |
PMID:28659758 |
|
NCBI chr 8:109,589,735...109,601,481
Ensembl chr 8:109,589,706...109,601,480
|
|